Filana Therapeutics receives Nasdaq delisting notice over sub-$1.00 bid price

FILANA THERAPEUTICS, INC.

Received Nasdaq notice Sept 17, 2026; bid price below $1.00 for 30 consecutive business days.
Non-compliant with Nasdaq Listing Rule 5550(a)(2) minimum bid price requirement.
Has 180 calendar days until March 16, 2027 to regain compliance.
Must close at $1.00+ for 10 consecutive business days; second 180-day period possible.
Stock continues trading on Nasdaq Capital Market under symbol FLNA.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.